Evaluating natalizumab first-line and later-line use in multiple sclerosis: a US claims database analysis by Robin L. Avila, Nicole S. Croteau, Fei Tang, Jason C. Simeone, Khalil Jomaa, Boyang Bian, Mattia Gianinazzi

Get full text

Real-World Treatment Outcomes in Black, Hispanic, Asian, and White Patients with Multiple Sclerosis Treated with Natalizumab by Karen Blitz-Shabbir, Aimee M. Banks, Hina Garg, Flavia Nelson, Suma Shah, Nicholas Belviso, Jason P. Mendoza, Robin L. Avila, Boyang Bian, Kinyee Fong

Get full text

Comparative Effectiveness of Fumarates Versus Sphingosine-1-Phosphate Receptor Modulators in Black Patients with Multiple Sclerosis by Sophia Woodson, Edward J. Gettings, Chu-Yueh Guo, Sylvia Klineova, Jong-Mi Lee, Rebecca S. Romero, Aljoeson Walker, Nicholas Belviso, Sai L. Shankar, Jason P. Mendoza, Boyang Bian, James B. Lewin, Kinyee Fong

Get full text

Real-World Treatment Outcomes in Black, Hispanic, Asian, and White People with Multiple Sclerosis Treated with Fumarates in the USA by Sophia Woodson, Edward J. Gettings, Chu-Yueh Guo, Sylvia Klineova, Jong-Mi Lee, Rebecca S. Romero, Aljoeson Walker, Kinyee Fong, Jason P. Mendoza, Nicholas Belviso, Boyang Bian, James B. Lewin, Sai L. Shankar

Get full text